2/18/2021 7:44:03 AM
Cytokinetics Names Muna Bhanji To Board
1/13/2021 7:33:48 AM
Cytokinetics Says First Patient Dosed In Cohort 2 Of REDWOOD-HCM; Earns $2.5 Mln Milestone
1/11/2021 7:46:55 AM
Cytokinetics Says FDA Has Granted Orphan Drug Designation To CK-3773274
12/23/2020 7:35:41 AM
Cytokinetics Regains European Rights To Omecamtiv Mecarbil
12/1/2020 7:43:47 AM
Cytokinetics To Present Results From GALACTIC-HF At Global Cardiovascular Clinical Trialists Forum
11/23/2020 7:36:27 AM
Amgen Provides Notice To Cytokinetics Of Termination Of Its Collaboration For Omecamtiv Mecarbil And AMG 594
10/8/2020 8:36:09 AM
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF Trial Did Not Meet Secondary Endpoint
10/2/2020 8:00:52 AM
Cytokinetics Publishes Manuscript Detailing Baseline Characteristics Of GALACTIC-HF In European Journal
9/24/2020 7:45:26 AM
Cytokinetics Announces Call For Proposals For Third Annual Communications Fellowship Program
9/17/2020 7:43:57 AM
Cytokinetics Announces GALACTIC-HF Accepted For Presentation At AHA Scientific Sessions
7/14/2020 7:39:56 AM
Cytokinetics Agrees To Series Of Transactions With RTW And Ji Xing Related To CK-3773274
5/27/2020 7:37:54 AM
Cytokinetics And ALS Association Announce Continuation Of Their Partnership In The Fight Against ALS